Innovating Works

EPIGEM

Desconocido
RELEVANCE: Regulation of red cell life span erythropoiesis survival senescence and clearance EPIGEM LIMITED participó en un H2020: H2020-MSCA-ITN-2015 Anaemia is the most common pathological condition affecting 1.6 billion individuals worldwide. It thus presents a serious health care proble...
2015-08-03 - 2019-11-30 | Financiado
AQUAVALENS: Protecting the health of Europeans by improving methods for the detection of pathogens in drinking w... EPIGEM LIMITED participó en un FP7: The AQUAVALENS consortium has brought together SMEs, Industries, Universities and Research Institutes with the mission of protecting the hea...
Financiado
COMMITMENT: Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments EPIGEM LIMITED participó en un FP7: The aim of CoMMiTMenT is the development of combined imaging technologies based on optofluidic microscopy and scanning ion conductance micro...
Financiado
Flex-o-Fab: Pilot scale hybrid roll to roll sheet to sheet manufacturing chain for flexible OLEDs EPIGEM LIMITED participó en un FP7: Organic Electroluminescence (OLED) is the most promising technology to deliver flexible, thin, light weight, power efficient and environment...
Financiado
SYMPHONY: Integrated SYsteM based on PHOtonic Microresonators and Microfluidic Components for rapid detectioN... EPIGEM LIMITED participó en un FP7: In the milk industry, one of most pressing unmet needs is the timely detection of mycotoxins that originate from animal feed and are secrete...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.